CA2522446C - Compositions and methods for using a solid support to purify rna - Google Patents
Compositions and methods for using a solid support to purify rna Download PDFInfo
- Publication number
- CA2522446C CA2522446C CA2522446A CA2522446A CA2522446C CA 2522446 C CA2522446 C CA 2522446C CA 2522446 A CA2522446 A CA 2522446A CA 2522446 A CA2522446 A CA 2522446A CA 2522446 C CA2522446 C CA 2522446C
- Authority
- CA
- Canada
- Prior art keywords
- rna
- solid support
- lysing
- wash
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 136
- 239000007787 solid Substances 0.000 title claims description 155
- 239000000203 mixture Substances 0.000 title claims description 70
- 239000012620 biological material Substances 0.000 claims abstract description 88
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 48
- 239000000243 solution Substances 0.000 claims description 257
- 230000027455 binding Effects 0.000 claims description 129
- 238000009739 binding Methods 0.000 claims description 129
- 230000002934 lysing effect Effects 0.000 claims description 125
- 102000039446 nucleic acids Human genes 0.000 claims description 78
- 108020004707 nucleic acids Proteins 0.000 claims description 78
- 150000007523 nucleic acids Chemical class 0.000 claims description 78
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 77
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 64
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical group [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 64
- 229910003002 lithium salt Inorganic materials 0.000 claims description 64
- 159000000002 lithium salts Chemical class 0.000 claims description 64
- 239000003599 detergent Substances 0.000 claims description 60
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 47
- 210000004027 cell Anatomy 0.000 claims description 43
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 40
- 238000009472 formulation Methods 0.000 claims description 37
- 210000001519 tissue Anatomy 0.000 claims description 35
- 239000000872 buffer Substances 0.000 claims description 33
- 238000010828 elution Methods 0.000 claims description 28
- 239000006166 lysate Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- -1 bone marrow Substances 0.000 claims description 23
- 239000002738 chelating agent Substances 0.000 claims description 22
- 239000000377 silicon dioxide Substances 0.000 claims description 18
- 229910052792 caesium Inorganic materials 0.000 claims description 17
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 16
- 239000003638 chemical reducing agent Substances 0.000 claims description 16
- 238000005406 washing Methods 0.000 claims description 16
- 230000004570 RNA-binding Effects 0.000 claims description 15
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 14
- SGPUHRSBWMQRAN-UHFFFAOYSA-N 2-[bis(1-carboxyethyl)phosphanyl]propanoic acid Chemical group OC(=O)C(C)P(C(C)C(O)=O)C(C)C(O)=O SGPUHRSBWMQRAN-UHFFFAOYSA-N 0.000 claims description 11
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 11
- 239000004202 carbamide Substances 0.000 claims description 11
- 108020004418 ribosomal RNA Proteins 0.000 claims description 11
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- 108020004999 messenger RNA Proteins 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 8
- 108020004566 Transfer RNA Proteins 0.000 claims description 7
- 229920002678 cellulose Polymers 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229920000136 polysorbate Polymers 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 239000000020 Nitrocellulose Substances 0.000 claims description 6
- 239000004677 Nylon Substances 0.000 claims description 6
- 239000002033 PVDF binder Substances 0.000 claims description 6
- 239000004695 Polyether sulfone Substances 0.000 claims description 6
- 108020000999 Viral RNA Proteins 0.000 claims description 6
- 241000700605 Viruses Species 0.000 claims description 6
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 229920002301 cellulose acetate Polymers 0.000 claims description 6
- 230000007613 environmental effect Effects 0.000 claims description 6
- 229920001220 nitrocellulos Polymers 0.000 claims description 6
- 229920001778 nylon Polymers 0.000 claims description 6
- 229920000728 polyester Polymers 0.000 claims description 6
- 229920006393 polyether sulfone Polymers 0.000 claims description 6
- 229920000098 polyolefin Polymers 0.000 claims description 6
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 6
- 229910052701 rubidium Inorganic materials 0.000 claims description 6
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000003570 air Substances 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 5
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 5
- 210000002381 plasma Anatomy 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000002689 soil Substances 0.000 claims description 5
- FCKYPQBAHLOOJQ-UHFFFAOYSA-N Cyclohexane-1,2-diaminetetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)C1CCCCC1N(CC(O)=O)CC(O)=O FCKYPQBAHLOOJQ-UHFFFAOYSA-N 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- 241000606701 Rickettsia Species 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 125000000129 anionic group Chemical group 0.000 claims description 4
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 4
- 210000003608 fece Anatomy 0.000 claims description 4
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 239000013049 sediment Substances 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 claims description 3
- 241000204031 Mycoplasma Species 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 210000004243 sweat Anatomy 0.000 claims description 3
- 210000001138 tear Anatomy 0.000 claims description 3
- 238000000746 purification Methods 0.000 abstract description 45
- 229920002477 rna polymer Polymers 0.000 description 281
- 150000003839 salts Chemical class 0.000 description 54
- 239000007790 solid phase Substances 0.000 description 30
- 102000006382 Ribonucleases Human genes 0.000 description 24
- 108010083644 Ribonucleases Proteins 0.000 description 24
- 229910013470 LiC1 Inorganic materials 0.000 description 23
- 230000000694 effects Effects 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 21
- 102000053602 DNA Human genes 0.000 description 21
- 239000000463 material Substances 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 239000000523 sample Substances 0.000 description 20
- 230000003196 chaotropic effect Effects 0.000 description 19
- 102000004169 proteins and genes Human genes 0.000 description 19
- 238000002955 isolation Methods 0.000 description 17
- 239000012528 membrane Substances 0.000 description 17
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 230000009089 cytolysis Effects 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 150000003841 chloride salts Chemical class 0.000 description 12
- 239000000356 contaminant Substances 0.000 description 12
- 239000004094 surface-active agent Substances 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 11
- 238000000265 homogenisation Methods 0.000 description 11
- 238000001556 precipitation Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 239000012472 biological sample Substances 0.000 description 10
- 231100001261 hazardous Toxicity 0.000 description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical class [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 9
- 239000011543 agarose gel Substances 0.000 description 9
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000013614 RNA sample Substances 0.000 description 8
- 229920004890 Triton X-100 Polymers 0.000 description 8
- 239000013504 Triton X-100 Substances 0.000 description 8
- 235000019270 ammonium chloride Nutrition 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 239000007791 liquid phase Substances 0.000 description 8
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 8
- 150000003904 phospholipids Chemical class 0.000 description 8
- 230000003612 virological effect Effects 0.000 description 8
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 7
- 239000007983 Tris buffer Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 229910052783 alkali metal Inorganic materials 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 7
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 229910001416 lithium ion Inorganic materials 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 238000002123 RNA extraction Methods 0.000 description 6
- 238000010240 RT-PCR analysis Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 238000002493 microarray Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 150000003842 bromide salts Chemical class 0.000 description 5
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 5
- 239000003365 glass fiber Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000005388 borosilicate glass Substances 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical compound [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 3
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 108091006629 SLC13A2 Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 3
- 239000000383 hazardous chemical Substances 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229920002113 octoxynol Polymers 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 238000011530 RNeasy Mini Kit Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000000622 liquid--liquid extraction Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000010208 microarray analysis Methods 0.000 description 2
- 238000012775 microarray technology Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000010532 solid phase synthesis reaction Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical group 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- YDQXYRCYDMRJGD-UHFFFAOYSA-N chloroform;phenol;thiocyanic acid Chemical compound SC#N.ClC(Cl)Cl.OC1=CC=CC=C1 YDQXYRCYDMRJGD-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007728 cost analysis Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 229920002114 octoxynol-9 Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/418,194 | 2003-04-16 | ||
| US10/418,194 US7148343B2 (en) | 2001-10-12 | 2003-04-16 | Compositions and methods for using a solid support to purify RNA |
| PCT/US2004/012033 WO2004094635A2 (en) | 2003-04-16 | 2004-04-15 | Compositions and methods for using a solid support to purify rna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2522446A1 CA2522446A1 (en) | 2004-11-04 |
| CA2522446C true CA2522446C (en) | 2013-09-24 |
Family
ID=33309522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2522446A Expired - Lifetime CA2522446C (en) | 2003-04-16 | 2004-04-15 | Compositions and methods for using a solid support to purify rna |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7148343B2 (enExample) |
| EP (1) | EP1618194B1 (enExample) |
| JP (2) | JP4804347B2 (enExample) |
| CA (1) | CA2522446C (enExample) |
| WO (1) | WO2004094635A2 (enExample) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001516731A (ja) * | 1997-09-17 | 2001-10-02 | ジエントラ・システムズ・インコーポレーテツド | 核酸を単離するための装置および方法 |
| US7148343B2 (en) * | 2001-10-12 | 2006-12-12 | Gentra Systems, Inc. | Compositions and methods for using a solid support to purify RNA |
| US7893228B2 (en) * | 2001-10-12 | 2011-02-22 | Qiagen North American Holdings, Inc. | Compositions and methods for using a solid support to purify RNA |
| US20050032105A1 (en) * | 2001-10-12 | 2005-02-10 | Bair Robert Jackson | Compositions and methods for using a solid support to purify DNA |
| US7482116B2 (en) | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
| EA009302B1 (ru) * | 2003-05-20 | 2007-12-28 | Инвестиген, Инк. | Система обнаружения полинуклеотидов |
| JP2006528482A (ja) * | 2003-07-24 | 2006-12-21 | キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング | 核酸の逆転写及び／または増幅方法 |
| JP4435787B2 (ja) * | 2003-12-16 | 2010-03-24 | キアジェン ノース アメリカン ホールディングス，インコーポレイティド | タンパク質を変性させるための処方物および方法 |
| US7824855B2 (en) * | 2004-03-26 | 2010-11-02 | Fujifilm Corporation | Method for selectively separating and purifying RNA and method for separating and purifying nucleic acid |
| US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| US20080176209A1 (en) * | 2004-04-08 | 2008-07-24 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
| BRPI0509694A (pt) * | 2004-04-08 | 2007-10-09 | Biomatrica Inc | integração de armazenamento de amostra e administração de amostra para ciências biológicas |
| US20050277121A1 (en) * | 2004-06-11 | 2005-12-15 | Ambion, Inc. | Crude biological derivatives competent for nucleic acid detection |
| EP1809744B1 (en) * | 2004-11-05 | 2018-06-06 | QIAGEN North American Holdings, Inc. | Compositions and methods for purifying nucleic acids from stabilization reagents |
| EP1690938A1 (de) * | 2005-02-11 | 2006-08-16 | Qiagen GmbH | Verfahren zur Isolierung von Nukleinsäuren, wobei die Nukleinsäuren bei erhöhter Temperatur an einer Matrix immobilisiert werden |
| US20100311041A1 (en) * | 2005-06-14 | 2010-12-09 | Statens Serum Institut | Pcr diagnostics of dermatophytes and other pathogenic fungi |
| US20060286557A1 (en) * | 2005-06-15 | 2006-12-21 | Basehore Lee S | Combined lysis and PCR buffer |
| US20070015165A1 (en) * | 2005-07-13 | 2007-01-18 | Sigma-Aldrich Co. | Method for the isolation of RNA from biological sources |
| US20070092403A1 (en) * | 2005-10-21 | 2007-04-26 | Alan Wirbisky | Compact apparatus, compositions and methods for purifying nucleic acids |
| US20070202511A1 (en) * | 2006-02-28 | 2007-08-30 | Sigma-Aldrich Co. | Methods and compositions for the rapid isolation of small RNA molecules |
| GB0604973D0 (en) * | 2006-03-11 | 2006-04-19 | Central Science Lab Csl Of San | Purification method and kit |
| KR100785010B1 (ko) * | 2006-04-06 | 2007-12-11 | 삼성전자주식회사 | 수소 결합을 이용하여 고체 지지체의 친수성 표면 상에서핵산 정제 방법 및 장치 |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| EP2094846B8 (en) * | 2006-12-13 | 2013-10-16 | Roche Diagnostics GmbH | Use of tde for the isolation of nucleic acids |
| DE602007010986D1 (de) * | 2006-12-13 | 2011-01-13 | Roche Diagnostics Gmbh | Verwendung von acetalen zur isolation von nukleinsäuren |
| US20100015628A1 (en) * | 2007-02-28 | 2010-01-21 | Ge Healthcare Bio-Sciences Corp. | Ambient temperature stable chemical/biological reagents on membranes or filters |
| KR101443218B1 (ko) * | 2007-08-16 | 2014-09-24 | 삼성전자주식회사 | 코스모트로픽 염을 이용한 고체 지지체에서의 ｒｎａ 정제방법 |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| US20090053704A1 (en) * | 2007-08-24 | 2009-02-26 | Natalia Novoradovskaya | Stabilization of nucleic acids on solid supports |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| EP3058954B1 (en) | 2007-08-27 | 2017-03-01 | Longhorn Vaccines and Diagnostics, LLC | Immunogenic compositions and methods |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| US8357296B2 (en) | 2007-09-24 | 2013-01-22 | Emd Millipore Corporation | Centrifugal filter |
| ES2552858T3 (es) | 2007-10-01 | 2015-12-02 | Longhorn Vaccines And Diagnostics, Llc | Recogida de muestras biológicas y sistema de transporte y métodos de uso |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| KR101432034B1 (ko) * | 2007-11-16 | 2014-08-21 | 삼성전자주식회사 | 코스모트로픽 염을 이용한 고체 지지체에서의 작은 ｒｎａ분리 방법 |
| US7871764B1 (en) * | 2008-03-18 | 2011-01-18 | The United States Of America As Represented By The United States Department Of Energy | Universal nucleic acids sample preparation method for cells, spores and their mixture |
| TW201006517A (en) * | 2008-05-22 | 2010-02-16 | Asahi Kasei Medical Co Ltd | Filtration method |
| EP2163620A1 (de) * | 2008-09-03 | 2010-03-17 | Qiagen GmbH | Verfahren zum Isolieren und Reinigen von Nukleinsäuren |
| DE102008047790A1 (de) * | 2008-09-17 | 2010-04-15 | Qiagen Gmbh | Verfahren zur Normierung des Gehalts von Biomolekülen in einer Probe |
| EP2175020A1 (en) | 2008-10-13 | 2010-04-14 | Roche Diagnostics GmbH | Reduction of RNase activity in complex fluidic samples |
| WO2010120874A2 (en) | 2009-04-14 | 2010-10-21 | Chimeros, Inc. | Chimeric therapeutics, compositions, and methods for using same |
| WO2012018638A2 (en) * | 2010-07-26 | 2012-02-09 | Biomatrica, Inc. | Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
| EP2598661B1 (en) * | 2010-07-26 | 2017-09-27 | Biomatrica, INC. | Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
| US9255293B2 (en) * | 2010-11-01 | 2016-02-09 | Gen-Probe Incorporated | Integrated capture and amplification of target nucleic acid for sequencing |
| GB201103363D0 (en) * | 2011-02-28 | 2011-04-13 | Ge Healthcare Uk Ltd | Sample preservation method and sample application substrate |
| MX347611B (es) | 2011-06-19 | 2017-05-04 | Abogen Inc | Dispositivos, soluciones y metodos para recoleccion de muestras. |
| US9304070B2 (en) | 2011-07-13 | 2016-04-05 | Emd Millipore Corporation | All-in-one sample preparation device and method |
| AU2012305714A1 (en) | 2011-09-09 | 2014-03-27 | Biomed Realty, L.P. | Methods and compositions for controlling assembly of viral proteins |
| EP3494989B1 (en) | 2012-01-26 | 2025-07-16 | Longhorn Vaccines and Diagnostics, LLC | Composite antigenic sequences and vaccines |
| EP2820157B1 (en) | 2012-03-02 | 2019-05-01 | Winthrop-University Hospital | Method for using probe based pcr detection to measure the levels of circulating demethylated beta cell derived dna as a measure of beta cell loss in diabetes |
| CA2868805C (en) * | 2012-03-28 | 2018-09-04 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for the collection and isolation of nucleic acids from biological specimens |
| WO2014065395A1 (ja) | 2012-10-26 | 2014-05-01 | 株式会社カネカ | Ｒｎａ調製法 |
| EP3249054A1 (en) | 2012-12-20 | 2017-11-29 | Biomatrica, INC. | Formulations and methods for stabilizing pcr reagents |
| RU2717644C2 (ru) | 2014-03-07 | 2020-03-24 | ДиЭнЭй ГЕНОТЕК ИНК. | Способ, композиция и набор для стабилизации дезоксирибонуклеиновых кислот в биологических образцах |
| EP3942931A1 (en) | 2014-06-10 | 2022-01-26 | Biomatrica, INC. | Stabilization of thrombocytes at ambient temperatures |
| EP3218480A1 (en) | 2014-11-14 | 2017-09-20 | Corning Incorporated | Methods and kits for post-ivt rna purification |
| US10968443B2 (en) * | 2014-12-31 | 2021-04-06 | The Rockefeller University | Method of RNA isolation from clinical samples |
| EP3061822A1 (en) * | 2015-02-25 | 2016-08-31 | QIAGEN GmbH | Method for concentrating, isolating and/or purifying nucleic acids from highly diluted aqueous samples |
| GB201504459D0 (en) * | 2015-03-17 | 2015-04-29 | Moorlodge Biotech Ventures Ltd | Isolation of DNA |
| CA2985652C (en) | 2015-05-14 | 2020-03-10 | Gerald W. FISHER | Rapid methods for the extraction of nucleic acids from biological samples |
| KR20250047404A (ko) | 2015-12-08 | 2025-04-03 | 바이오매트리카 인코포레이티드 | 적혈구 침강 속도의 감소 |
| GB201609115D0 (en) * | 2016-05-24 | 2016-07-06 | Moorlodge Biotech Ventures Ltd | Isolating nucleic acids |
| US11112418B1 (en) * | 2016-07-29 | 2021-09-07 | Labrador Diagnostics Llc | Systems and methods for multi-analysis |
| SI3568475T1 (sl) * | 2017-01-16 | 2023-05-31 | Spectrum Solutions L. L. C. | Raztopina za ohranjanje nukleinske kisline in načini uporabe |
| EP3630971A1 (en) * | 2017-05-22 | 2020-04-08 | QIAGEN Healthcare Biotechnologies Systems Limited | Improvements in the recovery of nucleic acids from solid supports |
| CN108130325B (zh) * | 2018-02-02 | 2024-06-18 | 苏州优卡新材料科技有限公司 | 一种核糖核酸提取用无机材料滤芯的高效纯化柱 |
| CN108456674A (zh) * | 2018-03-26 | 2018-08-28 | 深圳市展行生物有限公司 | 一种Total RNA提取试剂及其制备方法 |
| CN109343143A (zh) * | 2018-10-09 | 2019-02-15 | 中国地质科学院矿产资源研究所 | 一种基于植物中锂元素含量预测隐伏锂矿床的方法 |
| WO2020085341A1 (ja) * | 2018-10-23 | 2020-04-30 | 東レ株式会社 | 核酸の回収方法及び核酸回収用のキット |
| CN113272314A (zh) * | 2018-11-14 | 2021-08-17 | 光谱解决方案有限责任公司 | Rna保存溶液及制造方法和使用方法 |
| MX2021005918A (es) | 2018-11-20 | 2021-08-24 | Spectrum Solutions Llc | Sistema de recoleccion de muestras que incluye una tapa de sellado y valvula. |
| US11701094B2 (en) | 2019-06-20 | 2023-07-18 | Spectrum Solutions L.L.C. | Sample collection system including valve and plug assemblies |
| US20230009972A1 (en) * | 2019-12-16 | 2023-01-12 | Qiagen Gmbh | Method for enriching vesicular rna |
| US12485166B2 (en) | 2020-02-06 | 2025-12-02 | Longhorn Vaccines And Diagnostics, Llc | Vaccines for the treatment and prevention of zoonotic infections |
| WO2021173983A1 (en) * | 2020-02-28 | 2021-09-02 | Somnio Global Holdings, Llc | Capillary assisted vitrification processes and materials for preservation of biological samples |
| GB2615470A (en) | 2020-10-20 | 2023-08-09 | Longhorn Vaccines & Diagnostics Llc | Immunogenic antigens |
| US20250258145A1 (en) * | 2022-04-20 | 2025-08-14 | Siemens Healthcare Diagnostics Inc. | Quantitation of alkylphenol ethoxylate compounds in aqueous samples |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4483920A (en) * | 1982-05-17 | 1984-11-20 | Hahnemann University | Immobilization of message RNA directly from cells onto filter material |
| DE3639949A1 (de) * | 1986-11-22 | 1988-06-09 | Diagen Inst Molekularbio | Verfahren zur trennung von langkettigen nukleinsaeuren |
| US5599667A (en) * | 1987-03-02 | 1997-02-04 | Gen-Probe Incorporated | Polycationic supports and nucleic acid purification separation and hybridization |
| US4843155A (en) * | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
| US5234809A (en) * | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| US5010183A (en) * | 1989-07-07 | 1991-04-23 | Macfarlane Donald E | Process for purifying DNA and RNA using cationic detergents |
| DE4034036C2 (de) | 1990-10-26 | 1994-03-03 | Diagen Inst Molekularbio | Vorrichtung und Verfahren zur Isolierung von Nukleinsäuren aus Zellsuspensionen |
| CA2067711C (en) * | 1991-05-03 | 2000-08-08 | Daniel Lee Woodard | Solid phase extraction purification of dna |
| US5155018A (en) * | 1991-07-10 | 1992-10-13 | Hahnemann University | Process and kit for isolating and purifying RNA from biological sources |
| US5346994A (en) * | 1992-01-28 | 1994-09-13 | Piotr Chomczynski | Shelf-stable product and process for isolating RNA, DNA and proteins |
| AU6230594A (en) * | 1993-02-01 | 1994-08-29 | University Of Iowa Research Foundation, The | Quartenary amine surfactants and methods of using same in isolation of rna |
| DE4321904B4 (de) | 1993-07-01 | 2013-05-16 | Qiagen Gmbh | Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen |
| GB9314249D0 (en) | 1993-07-09 | 1993-08-18 | Proofname Ltd | Purification method and apparatus |
| US5637687A (en) * | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
| ATE184013T1 (de) | 1994-06-14 | 1999-09-15 | Invitek Gmbh | Universelles verfahren zur isolierung und reinigung von nukleinsäuren aus extrem geringen mengen sowie sehr stark verunreinigten unterschiedlichsten ausgangsmaterialien |
| US6037465A (en) * | 1994-06-14 | 2000-03-14 | Invitek Gmbh | Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials |
| GB9425138D0 (en) | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| WO1996030545A1 (en) * | 1995-03-24 | 1996-10-03 | Mitokor | Mutation detection by differential primer extension of mutant and wildtype target sequences |
| US5945515A (en) * | 1995-07-31 | 1999-08-31 | Chomczynski; Piotr | Product and process for isolating DNA, RNA and proteins |
| US5973137A (en) * | 1996-02-13 | 1999-10-26 | Gentra Systems, Inc. | Low pH RNA isolation reagents, method, and kit |
| JP3082908B2 (ja) * | 1996-07-12 | 2000-09-04 | 東洋紡績株式会社 | リボ核酸の単離方法 |
| DE69734263T2 (de) | 1996-07-12 | 2006-07-13 | Toyo Boseki K.K. | Verfahren zur Isolierung von Ribonucleinsäuren. |
| US5939259A (en) * | 1997-04-09 | 1999-08-17 | Schleicher & Schuell, Inc. | Methods and devices for collecting and storing clinical samples for genetic analysis |
| US6218531B1 (en) * | 1997-06-25 | 2001-04-17 | Promega Corporation | Method of isolating RNA |
| US5958677A (en) * | 1997-07-28 | 1999-09-28 | The New York Blood Center, Inc. | Method for purifying viral nucleic acids |
| US6207370B1 (en) * | 1997-09-02 | 2001-03-27 | Sequenom, Inc. | Diagnostics based on mass spectrometric detection of translated target polypeptides |
| JP2001516731A (ja) * | 1997-09-17 | 2001-10-02 | ジエントラ・システムズ・インコーポレーテツド | 核酸を単離するための装置および方法 |
| US5972613A (en) * | 1997-12-09 | 1999-10-26 | The Perkin-Elmer Corporation | Methods of nucleic acid isolation |
| DE19858447A1 (de) * | 1997-12-18 | 1999-07-01 | Invitek Gmbh | Verfahren zur Isolierung von kurz- und langkettigen Nukleinsäuren |
| JPH11196869A (ja) * | 1998-01-19 | 1999-07-27 | Toyobo Co Ltd | リボ核酸の単離方法 |
| ZA99493B (en) * | 1998-01-30 | 1999-07-22 | Akzo Nobel Nv | Method for the isolation of nucleic acid. |
| WO1999039009A1 (en) | 1998-02-02 | 1999-08-05 | Gentra Systems, Inc. | Processes for isolating, amplifying and characterizing dna |
| US6090593A (en) * | 1998-05-13 | 2000-07-18 | The United States Of America As Represented By The Secretary Of The Air Force | Isolation of expressed genes in microorganisms |
| US6204375B1 (en) * | 1998-07-31 | 2001-03-20 | Ambion, Inc. | Methods and reagents for preserving RNA in cell and tissue samples |
| JP3183458B2 (ja) * | 1998-08-12 | 2001-07-09 | 農林水産省国際農林水産業研究センター所長 | 植物の転写因子をコードする遺伝子 |
| US6777210B1 (en) * | 1998-09-24 | 2004-08-17 | Ambion, Inc. | Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1 |
| US6958392B2 (en) * | 1998-10-09 | 2005-10-25 | Whatman, Inc. | Methods for the isolation of nucleic acids and for quantitative DNA extraction and detection for leukocyte evaluation in blood products |
| DE19856064C2 (de) * | 1998-12-04 | 2000-11-30 | Invitek Gmbh | Universelles Verfahren zur Isolierung von DNA aus beliebigen Ausgangsmaterialien |
| US6270970B1 (en) * | 1999-05-14 | 2001-08-07 | Promega Corporation | Mixed-bed solid phase and its use in the isolation of nucleic acids |
| US20060276629A9 (en) * | 1999-12-17 | 2006-12-07 | Hildebrand William H | Purification and characterization of soluble human HLA proteins |
| JP3922420B2 (ja) * | 2000-04-18 | 2007-05-30 | 東洋紡績株式会社 | 改良されたリボ核酸の単離方法 |
| US6919307B2 (en) * | 2000-11-01 | 2005-07-19 | Praecis Pharmaceuticals, Inc. | Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| US6602718B1 (en) * | 2000-11-08 | 2003-08-05 | Becton, Dickinson And Company | Method and device for collecting and stabilizing a biological sample |
| US6503716B1 (en) * | 2000-11-28 | 2003-01-07 | Pe Corporation (Ny) | Compositions and methods for extracting a nucleic acid |
| US6818398B2 (en) * | 2000-12-29 | 2004-11-16 | The University Of Chicago | Column device for isolation and labeling of nucleic acids |
| US20020106686A1 (en) * | 2001-01-09 | 2002-08-08 | Mckernan Kevin J. | Methods and reagents for the isolation of nucleic acids |
| AU2002211719B2 (en) * | 2001-10-12 | 2007-06-14 | Qiagen North American Holdings, Inc. | Compositions and methods for using a solid support to purify RNA |
| US20050032105A1 (en) * | 2001-10-12 | 2005-02-10 | Bair Robert Jackson | Compositions and methods for using a solid support to purify DNA |
| US7148343B2 (en) * | 2001-10-12 | 2006-12-12 | Gentra Systems, Inc. | Compositions and methods for using a solid support to purify RNA |
| US7893228B2 (en) * | 2001-10-12 | 2011-02-22 | Qiagen North American Holdings, Inc. | Compositions and methods for using a solid support to purify RNA |
| DK1442045T3 (da) * | 2001-11-06 | 2009-02-09 | Cortex Biochem Inc | Isolering og oprensning af nukleinsyrer |
| JP4220164B2 (ja) * | 2002-02-06 | 2009-02-04 | 東洋紡績株式会社 | 核酸の精製方法および当該方法に用いる核酸抽出用溶液ならびに核酸精製用試薬キット |
| DE10231659B4 (de) * | 2002-07-12 | 2006-01-19 | Preanalytix Gmbh | Zusammensetzung zum Binden von Nukleinsäure an eine Festphase |
| GB0225197D0 (en) * | 2002-10-30 | 2002-12-11 | Univ Sheffield | Surface |
| WO2004058300A1 (en) * | 2002-12-20 | 2004-07-15 | E.I. Du Pont De Nemours And Company | Sequences diagnostic for foot and mouth disease |
| GB0230102D0 (en) * | 2002-12-23 | 2003-01-29 | Spinox Ltd | Apparatus and method for storing proteins |
| WO2005003346A1 (en) * | 2003-06-06 | 2005-01-13 | Applera Corporation | Purification device for ribonucleic acid in large volumes, and method |
| JP4435787B2 (ja) * | 2003-12-16 | 2010-03-24 | キアジェン ノース アメリカン ホールディングス，インコーポレイティド | タンパク質を変性させるための処方物および方法 |
| EP1809744B1 (en) * | 2004-11-05 | 2018-06-06 | QIAGEN North American Holdings, Inc. | Compositions and methods for purifying nucleic acids from stabilization reagents |
| KR100691372B1 (ko) * | 2005-10-19 | 2007-03-12 | 삼성전기주식회사 | 신뢰성이 확보된 전해액을 포함하는 전기 습윤 장치 |
| US20070092403A1 (en) * | 2005-10-21 | 2007-04-26 | Alan Wirbisky | Compact apparatus, compositions and methods for purifying nucleic acids |
| US20070141583A1 (en) * | 2005-12-20 | 2007-06-21 | Weiwei Li | Methods of rapid chromatin immunoprecipitation |
| US7538190B2 (en) * | 2006-02-17 | 2009-05-26 | Polychip Pharmaceuticals Pty Ltd | Methods for the synthesis of two or more dicarba bridges in organic compounds |
| EP2035540A2 (en) * | 2006-06-15 | 2009-03-18 | Stratagene | System for isolating biomolecules from a sample |
-
2003
- 2003-04-16 US US10/418,194 patent/US7148343B2/en not_active Expired - Lifetime
-
2004
- 2004-04-15 EP EP04760008.5A patent/EP1618194B1/en not_active Expired - Lifetime
- 2004-04-15 CA CA2522446A patent/CA2522446C/en not_active Expired - Lifetime
- 2004-04-15 WO PCT/US2004/012033 patent/WO2004094635A2/en not_active Ceased
- 2004-04-15 JP JP2006513124A patent/JP4804347B2/ja not_active Expired - Lifetime
-
2006
- 2006-10-30 US US11/589,364 patent/US7767804B2/en not_active Expired - Lifetime
-
2010
- 2010-08-16 JP JP2010181955A patent/JP2010263919A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US7148343B2 (en) | 2006-12-12 |
| US7767804B2 (en) | 2010-08-03 |
| US20040019196A1 (en) | 2004-01-29 |
| EP1618194B1 (en) | 2016-11-23 |
| US20070043216A1 (en) | 2007-02-22 |
| JP4804347B2 (ja) | 2011-11-02 |
| JP2010263919A (ja) | 2010-11-25 |
| WO2004094635A3 (en) | 2004-12-16 |
| CA2522446A1 (en) | 2004-11-04 |
| EP1618194A2 (en) | 2006-01-25 |
| JP2006523463A (ja) | 2006-10-19 |
| WO2004094635A2 (en) | 2004-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2522446C (en) | Compositions and methods for using a solid support to purify rna | |
| US10947527B2 (en) | Compositions and methods for purifying nucleic acids from stabilization reagents | |
| EP1773996B1 (en) | Compositions and methods for using a solid support to purify dna | |
| CA2549985C (en) | Formulations and methods for denaturing proteins | |
| US7893228B2 (en) | Compositions and methods for using a solid support to purify RNA | |
| AU2002211719B2 (en) | Compositions and methods for using a solid support to purify RNA | |
| AU2002211719A1 (en) | Compositions and methods for using a solid support to purify RNA | |
| AU2004233035B2 (en) | Compositions and methods for using a solid support to purify RNA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20240415 |